한국형 우울장애 약물치료 알고리듬 2021 (III): 소아·청소년

키워드

참고문헌 (40)

1. 조수철, "한국어판 DISC-Ⅳ(Diagnostic Interview Schedule for Children Version Ⅳ)의 신뢰도 및 타당도", Journal of the Korean Academy of Child and Adolescent Psychiatry, 18(2), pp.138~144 (2007), 대한소아청소년 정신의학회
2. Behavioral health trends in the United States: results from the 2014 National Survey on Drug Use and Health, "Center for Behavioral Health Statistics and Quality", Substance Abuse and Mental Health Services Administration, ~, pp.HHS Publication No. SMA 15-4927 (2015)
3. Birmaher B, "Childhood and adolescent depression: a review of the past 10 years. Part I", J Am Acad Child Adolesc Psychiatry, 35, pp.1427~1439 (1996)
4. Giedd JN, "Brain development during childhood and adolescence : a longitudinal MRI study", Nat Neurosci, 2, pp.861~863 (1999)
5. 서정석, "한국형 우울장애 약물치료 알고리듬 2006 (Ⅰ)", 신경정신의학, 46(5), pp.453~460 (2007), 대한신경정신의학회
6. Seo SJ, "The Korean Medication Algorithm for Depressive Disorder : second revision", J Affect Disord, 167, pp.312~321 (2014)
7. Jeong Seok Seo, "Korean Medication Algorithm for Depressive Disorders 2017: Third Revision", Clinical Psychopharmacology and Neuroscience, 16(1), pp.67~87 (2018), 대한정신약물학회[DOI]
8. 심세훈, "한국형 우울장애 약물치료 알고리듬 2017(V) : 소아·청소년", 노인, Mood and Emotion, pp.2017, 15(2)[DOI]
9. Sachs GS, "The expert consensus guideline series : medication treatment of bipolar disorder 2000", Postgrad Med, pp.1~104 (2000)
10. Birmaher B, "Practice parameter for the assessment and treatment of children and adolescents with depressive disorders", J Am Acad Child Adolesc Psychiatry, 46, pp.1503~1526 (2007)
11. Baweja R, "Disruptive mood dysregulation disorder : current insights", Neuropsychiatr Dis Treat, 12, pp.2115~2124 (2016)
12. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders: DSM-5" (2013), American Psychiatric Publishing
13. Blader JC, "Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy", Am J Psychiatry, 166, pp.1392~1401 (2009)
14. Yoo HK, "Openlabel study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders", Eur Child Adolesc Psychiatry, 20, pp.127~135 (2011)
15. Tomson T, "Dose-dependent risk of malformations with antiepileptic drugs : an analysis of data from the EURAP epilepsy and pregnancy registry", Lancet Neurol, 10, pp.609~617 (2011)
16. Meador K, "Pregnancy outcomes in women with epilepsy: a systematic review and metaanalysis of published pregnancy registries and cohorts", Epilepsy Res, 81, pp.1~13 (2008)
17. Fountoulakis KN, "The International College of Neuro-Psychopharmacology (CINP)treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 3: the clinical guidelines", Int J Neuropsychopharmacol, 20, pp.180~195 (2017)
18. Grunze H, "The World Federation of Societies of Biological Psychiatry(WFSBP)guidelines for the biological treatment of bipolar disorders : acute and long-term treatment of mixed states in bipolar disorder", World J Biol Psychiatry, 19, pp.2~58 (2018)
19. Hughes CW, "Texas Children’s Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder", J Am Acad Child Adolesc Psychiatry, 46, pp.667~686 (2007)
20. MacQueen GM, "Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 6. Special populations:youth, women, and the elderly", Can J Psychiatry, 61, pp.588~603 (2016)
21. Weisz JR, "Effects of psychotherapy for depression in children and adolescents : a meta-analysis", Psychol Bull, 132, pp.132~149 (2006)
22. Klein JB, "Cognitive-behavioral therapy for adolescent depression : a meta-analytic investigation of changes in effect-size estimates", J Am Acad Child Adolesc Psychiatry, 46, pp.1403~1413 (2007)
23. Angold A, "Comorbidity", J Child Psychol Psychiatry, 40, pp.57~87 (1999)
24. Emslie GJ, "Treatment of Resistant Depression in Adolescents(TORDIA) : week 24 outcomes", Am J Psychiatry, 167, pp.782~791 (2010)
25. Lee ES, "A focused review on the treatment of pediatric patients with atypical antipsychotics", J Child Adolesc Psychopharmacol, 28, pp.582~605 (2018)
26. Kalverdijk LJ, "A multi-national comparison of antipsychotic drug use in children and adolescents, 2005-2012", Child Adolesc Psychiatry Ment Health, 11, pp.55~ (2017)
27. Patkar AA, "Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorder", CNS Drugs, 27(Suppl 1), pp.S29~S37 (2013)
28. Zhou X, "Atypical antipsychotic augmentation for treatment-resistant depression : a systematic review and network meta-analysis", Int J Neuropsychopharmacol, 18 (2015)
29. Nelson JC, "Atypical antipsychotic augmentation in major depressive disorder : a meta-analysis of placebo-controlled randomized trials", Am J Psychiatry, 166, pp.980~991 (2009)
30. Seida JC, "Antipsychotics for children and young adults : a comparative effectiveness review", Pediatrics, 129, pp.e771~e784 (2012)
31. Solmi M, "Safety of 80 antidepressants, antipsychotics, anti-attention-deficit", hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic metareview of 78 adverse effects, 2020, pp.19, 214~232
32. Hetrick SE, "Newer generation antidepressants for depressive disorders in children and adolescents", Cochrane Database Syst Rev, (11) (2012)
33. Wagner KD, "A doubleblind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression", J Am Acad Child Adolesc Psychiatry, 45, pp.280~288 (2006)
34. Zhou X, "Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis", Lancet Psychiatry, 7, pp.581~601 (2020)
35. Cipriani A, "Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis", Lancet, 388, pp.881~890 (2016)
36. Findling RL, "Escitalopram in the treatment of adolescent depression: a randomized, double-blind, placebo-controlled extension trial", J Child Adolesc Psychopharmacol, 23, pp.468~480 (2013)
37. Cipriani A, "Escitalopram versus other antidepressive agents for depression", Cochrane Database Syst Rev, (2) (2009)
38. Kukju Kweon, "Effectiveness and Safety of Bupropion in Children and Adolescents with Depressive Disorders: A Retrospective Chart Review", Clinical Psychopharmacology and Neuroscience, 17(4), pp.537~541 (2019), 대한정신약물학회[DOI]
39. Song J, "Comparative study of the effects of bupropion and escitalopram on internet gaming disorder", Psychiatry Clin Neurosci, 70, pp.527~535 (2016)
40. 남범우, "Comparing the Effects of Bupropion and Escitalopram on Excessive Internet Game Play in Patients with Major Depressive Disorder", Clinical Psychopharmacology and Neuroscience, 15(4), pp.361~368 (2017), 대한정신약물학회[DOI]

관련 논문AI추천